olivomycin a has been researched along with olivomycins in 8 studies
Studies (olivomycin a) | Trials (olivomycin a) | Recent Studies (post-2010) (olivomycin a) | Studies (olivomycins) | Trials (olivomycins) | Recent Studies (post-2010) (olivomycins) |
---|---|---|---|---|---|
11 | 0 | 6 | 237 | 3 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bradner, WT; Kumar, V; Remers, WA | 1 |
Hou, D; Lowary, TL | 1 |
Bukhman, VM; Dezhenkova, LG; Durandin, NA; Isakova, EB; Kuzmin, VA; Luzikov, YN; Olsufyeva, EN; Preobrazhenskaya, MN; Reznikova, MI; Shtil, AA; Tevyashova, AN; Vinogradov, AM | 1 |
Bykov, EE; Dezhenkova, LG; Durandin, NA; Kuzmin, VA; Olsufyeva, EN; Preobrazhenskaya, MN; Reznikova, MI; Shtil, AA; Tevyashova, AN; Vinogradov, AM; Zbarsky, VB | 1 |
Beniaminov, AD; Dezhenkova, LG; Kaluzhny, DN; Mamaeva, OK; Shchyolkina, AK; Shtil, AA; Tevyashova, AN | 1 |
Gromova, ES; Sergeev, AV; Tevyashova, AN; Vorobyov, AP | 1 |
Beniaminov, AD; Chashchina, GV; Kaluzhny, DN; Kechko, OI; Livshits, MA; Mamaeva, OK; Mitkevich, VA; Shchyolkina, AK; Shtil, AA; Tevyashova, AN | 1 |
Beniaminov, AD; Isagulieva, AK; Kaluzhny, DN; Shtil, AA; Soshnikova, NV | 1 |
8 other study(ies) available for olivomycin a and olivomycins
Article | Year |
---|---|
Preparation and antitumor activity of olivomycin A analogues.
Topics: Animals; Antibiotics, Antineoplastic; DNA; Female; Leukemia P388; Mice; Olivomycins; Structure-Activity Relationship | 1980 |
2,3-Anhydrosugars in glycoside bond synthesis. Application to 2,6-dideoxypyranosides.
Topics: Biological Products; Glycosides; Glycosylation; Macrolides; Monosaccharides; Oligosaccharides; Olivomycins | 2009 |
Modification of olivomycin A at the side chain of the aglycon yields the derivative with perspective antitumor characteristics.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; DNA; Female; Humans; Lymphoma; Melanoma; Mice; Olivomycins | 2011 |
Role of the acyl groups in carbohydrate chains in cytotoxic properties of olivomycin A.
Topics: Antibiotics, Antineoplastic; Carbohydrates; Cations, Divalent; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Magnesium; Olivomycins | 2013 |
Divalent cations are dispensable for binding to DNA of a novel positively charged olivomycin A derivative.
Topics: Binding Sites; Cations, Divalent; Circular Dichroism; DNA; Electrophoresis, Agar Gel; Olivomycins; Spectrometry, Fluorescence; Static Electricity | 2018 |
The Effect of Antitumor Antibiotic Olivomycin A and Its New Semi-synthetic Derivative Olivamide on the Activity of Murine DNA Methyltransferase Dnmt3a.
Topics: Animals; Antibiotics, Antineoplastic; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Mice; Olivomycins; Protein Binding | 2019 |
Discrimination between G/C Binding Sites by Olivomycin A Is Determined by Kinetics of the Drug-DNA Interaction.
Topics: Circular Dichroism; CpG Islands; DNA; Kinetics; Olivomycins; Spectrometry, Fluorescence | 2020 |
Differential Impact of Random GC Tetrad Binding and Chromatin Events on Transcriptional Inhibition by Olivomycin A.
Topics: Binding Sites; Chromatin; DNA; Olivomycins; Promoter Regions, Genetic; RNA Polymerase II; Transcription Factors; Transcription, Genetic | 2022 |